Neurology Research International

Neurology Research International / 2011 / Article

Research Article | Open Access

Volume 2011 |Article ID 829365 | 7 pages | https://doi.org/10.1155/2011/829365

Evaluation of Heart Rate Variation Analysis during Rest and Tilting in Patients with Temporal Lobe Epilepsy

Academic Editor: Mamede de Carvalho
Received18 Nov 2010
Revised15 Mar 2011
Accepted24 May 2011
Published14 Jul 2011

Abstract

Objective. To evaluate spectral heart rate (HR) variation using short-term ECG recordings at rest and during the tilt table test. Methods. The values of spectral components of total power (TP), high-frequency power (HF), low-frequency power (LF) and LF: HF ratio were measured at rest and during the head-up tilt in patients with temporal lobe epilepsy (TLE) and their control subjects. Results. Compared to the control subjects, patients with TLE had lower HF ( ) and LF : HF ratio ( ) at rest and lower TP ( ), HF ( ), and LF ( ) during the head-up tilt. Upon changing from supine to standing position TP ( ) and LF ( ) were attenuated in patients with TLE compared to the control subjects. Conclusion. These results suggest that spectral analysis of HR variation from ECG recordings of short duration may add value to assessment of autonomic nervous system function using autonomic cardiac tests in patients with TLE.

1. Introduction

Epilepsy is well known to be associated with various autonomic phenomena [1, 2]. Both ictal and interictal changes in cardioregulatory function of the autonomic nervous system (ANS) have been described in previous studies [319]. Although their prognostic role is not yet established in patients with epilepsy, similar changes in heart rate (HR) variation described in patients with epilepsy have been detected in other chronic diseases and shown to be associated with an unfavourable prognosis in patients with various heart conditions and cerebrovascular diseases [2025]. Moreover, it has been suggested that unstable cardiac and respiratory control of the ANS may contribute to sudden unexpected death in epilepsy (SUDEP) [2633].

Autonomic cardiovascular regulation can be assessed with different methods [28, 34]. The test pattern of autonomic cardiac function is performed under standardised environmental conditions. The adaptive responses of the ANS to various stimuli are assessed during the test [34]. Although the analysis of HR variation from an ECG of short duration obtained during the autonomic cardiac function tests may not be as sensitive as spectral analyses of HR variation from 24-hour Holter recordings in revealing subtle abnormalities in linear as well as dynamic fluctuations of HR variation, the method provides valuable information when conducted according to the strict protocol developed [34, 35]. Spectral analyses of HR variation can also be performed from the short ECG recordings obtained during the autonomic function tests. This allows assessment of the ability of the autonomic cardioregulatory functions to maintain the homeostasis of the body in standardized dynamic conditions.

In this study, spectral measures of HR variation were analysed post hoc from ECG data obtained during the normal breathing and tilt-table tests of the autonomic cardiac reactivity evaluation in patients with temporal lobe epilepsy (TLE) and control subjects. The results of the autonomic cardiac function tests of these patients have been previously published [8]. Spectral analysis of HR variation from 24-hour ECG recordings has also been conducted in these same patients, and the results showed decreased overall autonomic cardiac regulation associated with TLE [10]. A recent study by DeGiorgio et al. showed that low values of certain parameters of HR variability correlate with clinical risk markers of SUDEP [36]. Although the risk evaluation of SUDEP cannot be solely based on ANS function, it is important to try to develop easily accessible methods to detect autonomic instability in epilepsy patients. Our aim was to evaluate the value of analysing spectral HR variation from ECG recordings obtained during autonomic cardiac measures and further the dynamic reactivity of the cardiac regulation in TLE patients during these tests as a tool to assess cardioregulatory function in these subjects.

2. Materials and Methods

2.1. Patients and Control Subjects

The study was carried out at the Outpatient Department of Neurology in the University Hospital, with the approval of the Ethics Committee of the local Medical Faculty.

Thirty-six patients with TLE who were followed up in the Outpatient Clinic participated in the study after giving their informed consent. Eighteen patients suffered from recurrent TLE seizures despite adequate AED treatment, and 18 patients had well-controlled TLE (seizure-free on AEDs or <2 seizures/year). Both patient groups consisted of four male and 14 female consecutive patients. The control group consisted of 36 healthy age- and sex-matched subjects who were either hospital staff or were recruited by the staff. The subjects were eligible for the study if they did not have a disease or medication known to affect the ANS in their medical history and if the complete physical examination findings were normal.

The results of heart rate and blood pressure (BP) responses to normal and deep breathing, tilt-table test, and isometric work conducted with present patients and control subjects were analysed and published previously [8]. In short, HR variation was lower in refractory TLE patients than in control subjects during normal breathing ( ) and tilting ( ), and HR was also low in well-controlled TLE patients compared to control subjects during tilting ( ). BP responses showed no differences between the patients and the control subjects. We were able to successfully perform the spectral analysis of HR variation from the ECG data of 36 patients, who represent a subset of the original 38 patients who participated in the autonomic cardiac function tests. The demographics of the study patients and the control subjects are shown in Table 1.


No. of patients/control subjectsAge, years, mean (SD)Duration of epilepsy years, mean (SD)

Patients with refractory TLE1833 (7) 22 (11)

Patients with well-controlled TLE1835 (6)15 (10)

Patients, total3634 (7)19 (11)

Control subjects3634 (7)

Nine patients were taking CBZ, 11 patients were taking oxcarbazepine (OXC), and one patient was taking phenytoin, valproate, or lamotrigine each as monotherapy, and thirteen patients were on polytherapy as a combination of two to four of the above-mentioned antiepileptic drugs (AEDs). In addition, vigabatrin, clonazepam, and clobazam were all taken as part of polytherapy by one patient each. All thirteen patients who were on polytherapy had refractory TLE.

All patients were carefully interviewed and clinically examined. The epilepsy type was classified according to the recommendations of the International League Against Epilepsy [37]. None of the patients showed any symptoms or signs of illness other than epilepsy known to affect the ANS. In general, the patients had neither excessive body weight, nor elevated blood pressure. Laboratory screening (liver and renal function, serum electrolytes, and basic hematologic parameters) was normal in all study patients.

Patients abusing alcohol or drugs or taking any medication other than AEDs known to affect the ANS were excluded. Female patients who were pregnant or lactating were also excluded.

2.2. Methods
2.2.1. Autonomic Cardiac Function Tests

All patients and control subjects underwent autonomic cardiac function testing that is based on HR and BP responses at rest and after various stimuli. All tests were performed under standardized conditions. The measurements were performed in a silent room with a temperature from 20 to 23°C between 9 a.m. and 12 a.m. The study subjects were asked not to smoke or drink coffee within two hours and not to use alcohol within 48 hours prior to the study. The interval between the various tests was standardized so that the next test did not start until the HR and BP had returned to the baseline level after the previous test. HR and BP responses at rest and after stimulation were recorded under the following conditions: normal breathing, deep breathing, the Valsalva maneuver, tilting, and isometric work (handgrip). ECG was first recorded during the normal breathing. Consecutive RR intervals were measured from the ECG for a period of 10 min and the standard deviation of the intervals was used as the test variable. In the tilt table test, the HR responses to quick passive tilting (2 s, 90°) and after tilting (7 min) were recorded. A more detailed description of the methodology of the autonomic cardiac test pattern of the patients and control subjects has been previously published [8, 35].

2.2.2. HRV Analysis

Spectral analysis of the RR series of all patients and controls was performed with direct Fourier transformation [25]. The length of the time series was 10 min for the normal breathing test and 7 min for the tilt table test. RR intervals at rest and while standing were converted to a smoothed instantaneous RR time series at 4 Hz after manual editing of ectopic beats, and exact Hamming windowing (cos2) was applied before Fourier transformation. Total power (TP; 0.0033–0.40 Hz) and the components of high frequency (HF; 0.15–0.40 Hz) and low frequency (LF; 0.04–0.15 Hz) were identified for each subject visually from the Fourier series, and the HF band was manually selected according to the calculated actual respiration frequency spectrum. The LF : HF ratio was also calculated. The very-low-frequency band (VLF; 0.0033–0.04 Hz) was not included in the analysis because the adequate calculation of VLF requires a minimum of 12–16 hours of HR data [25].

2.2.3. Statistics

The nonparametric Mann-Whitney test was used in analysing unevenly distributed data. The difference of the changes of various measures of HR variation from supine to standing position was studied using the repeated measures analysis of variance. Because of unevenly distributed data, Tables 2 and 3 show the data as median (percentiles). However, as the data of analysis of repeated measures follows normal (Gaussian) distribution, the data in Table 4 is shown as mean (SD). The -value of the interaction describing this change is reported in Table 4 and Figure 1. The -value of ≤0.05 was considered to indicate a statistically significant difference. The statistical tests were performed with SPSS 14.0 software (SPSS Inc., Chicago, IL, USA).


Measure/
variable (ms2)
Patients with refractory TLEPatients with well-controlled TLEAll patientsControl subjectsP-value (Mann-Whitney)

TP7417 (6276, 11043)8093 (7016, 1044)7991 (6292, 10521)9518 (6742, 13923 )0.33
HF2471 (1752, 3622)2954 (2092, 4397)2729 (1979, 4265)3954 (2855, 5705)0.03
LF2284 (1864, 3505)2855 (2117, 3449)2691 (1876, 3416)2604 (1583, 4091)0.54
LF : HF ratio0.90 (0.76, 1.25 )0.91 (0.70, 1.12)0.90 (0.75, 1.12)0.84 (0.65, 1.16)0.003

Values are median (25., 75. percentile); TP: total power; HF: high frequency; LF: low frequency.

Measure/
variable (ms2)
Patients with refractory TLEPatients with well-controlled TLEAll patientsControl subjectsP-value (Mann-Whitney)

TP8897 (7076, 1444)10822 (8543, 12619)10314 (8182, 13359)14022 (11262, 17916)<0.001
HF2175 (1250, 3918)2428 (2017, 3113)2347 (1810, 3336)3221 (2482, 4780)0.004
LF4248 (2525, 6035)4326 (3682, 5687)4248 (3198, 5633)5800 (4308, 7142)0.001
LF : HF ratio1.73 (1.26, 2.31)1.73 (1.41, 2.47)1.73 (1.36, 2.33)1.64 (1.35, 2.34)0.85

Values are median (25., 75. percentile); TP: total power; HF: high frequency; LF: low frequency.

Measure/
variable (ms2)
Patients with refractory TLEPatients with well-controlled TLEAll patientsControl subjectsP-value (interaction)

TP173 (438)243 (222)208 (344)504 (596)0.01
HF−46 (175)−70 (122)−58 (149)−68 (282)0.85
LF157 (231)169 (142)163 (189)351 (279)0.001
LF : HF ratio0.90 (0.95)0.89 (0.83)0.89 (0.88)1.1 (0.700.23

Values are mean ± SD; TP: total power; HF: high frequency; LF: low frequency.

3. Results

3.1. Supine Position

HF was decreased ( ) and the LF : HF ratio was increased ( ) in patients with TLE compared to the control subjects at rest. The results of various analyses at rest are shown in Table 2. Patients with refractory TLE had lower values of TP, HF, and LF and higher LF : HF ratio than patients with well-controlled epilepsy, but the differences were not statistically significant.

3.2. Standing Position

During the head-up tilting TP ( ), HF ( ) and LF ( ) were low in patients with TLE compared to the control subjects, but the LF : HF ratio did not differ between the patients and the control subjects. The results of various analyses of head-up tilt are shown in Table 3. Patients with refractory TLE presented lower values of TP, HF, and LF and higher LF : HF ratio than patients with well-controlled TLE. However, the differences were not statistically significant.

3.3. Change from Supine to Standing

The changes in the powers of different spectra during this test are shown in Table 4. The differences of TP in changing from supine to standing position in both patient groups and control subjects are also shown in Figure 1. Changing from supine to standing position resulted in significantly lower response in HR variation in patients with TLE compared to the controls in TP ( ) and LF ( ). The changes in HF and LF : HF ratio were similar in the TLE patients and the control subjects. Although the absolute values of changes in different spectra were systematically lower in patients with refractory TLE compared to patients with well-controlled TLE both in supine and tilting position, none of these differences were statistically significant (Table 4, Figure 1).

4. Discussion

This study was conducted to evaluate whether spectral analysis of HR variation from short ECG recordings obtained during autonomic cardiac function test pattern adds value to the assessment of the ANS in patients with TLE. The results suggest that this method may be a useful tool to detect alterations of autonomic cardiac functions. Patients with TLE had altered HR variation already in the resting state, and during the dynamic state (head-up tilt) these alterations were even more pronounced. Dynamic malfunction of the ANS of the TLE patients upon changing from supine to tilting position was easily detected by using spectral analysis of HR variation. At rest, the emphasis of malfunction was on vagal modulation on the HR whereas during tilting both the sympathetic and vagal modulation of the ANS in TLE patients showed inferiority to that of the control subjects. Interestingly, change from supine to standing position revealed mainly a breakdown of the sympathovagal balance in these patients. Although no statistically significant differences were detected between the two patient groups, there was a consistent trend towards lower values of the test parameters in the refractory TLE group, indicating a more disrupted cardioregulatory function compared to well-controlled TLE patients.

Previous studies have shown altered cardioregulatory function in patients with TLE in cardiovascular function tests [5, 6, 8, 16, 38] and in spectral analyses of HR variation from 24-hour ECG recordings [4, 7, 10, 11, 13, 19]. Dysregulation of the cardiac autonomic functions has been described in association with various other diseases as well [2024], and the prognostic significance of these findings has been established in heart and cerebrovascular diseases [20, 21, 24]. The present study agrees well with the previous studies in that TLE affects autonomic cardiac regulation. However, this study also shows that in addition to having an overall suppressing effect on the ANS function, especially refractory TLE seems to be associated with decreased reactivity of the cardiovascular ANS system.

The possible contribution of AEDs to ANS dysfunction in patients with epilepsy has not been clearly established. Previous work has shown that CBZ alters autonomic functions in epilepsy patients [39, 40]. In one study, slow withdrawal of AEDs in seizure-free epilepsy patients resulted in an increase of both parasympathetic and sympathetic function of HR variation [41]. Since in the current study most patients were taking CBZ or OXC, and refractory TLE patients were on polytherapy, it was not possible to analyse the effects of different AEDs on HR variability. However, it is possible that AEDs contributed to the detected alterations in the cardioregulation, and studies designed to analyse the effects of different AED regimens on autonomic cardiac function are needed.

The frequency domain measure is one of the linear analyses of the HR variation, where the power spectrum of RR intervals reflects the amplitude of the HR fluctuations at different oscillation frequencies [25]. The HF represents the vagal modulation of the heart, the LF band represents the sympathetic cardiac innervation and parasympathetic activity whereas both the VLF band and the LH : HF ratio are assumed to represent the sympathovagal balance [25]. The frequency domain analysis of HR variation, along with various other indices are typically analysed from 24-hour ambulatory ECG-recordings. Although this method has the advantage that the information concerning the VLF band is gathered over a longer time period [25], the ambulatory recording may be interfered by stationary irregularities and artefacts in consequence of the patients carrying the device during their daily activities [42]. On the other hand, analysis of HR variation from ECGs obtained during the provocative autonomic testing, as shown in this study, may provide valuable information on the reactivity of the autonomic cardioregulation, and this method only requires a short period of time under standardised conditions.

It is well known that various cortical and subcortical autonomic areas control the cardiovascular function [18, 29, 4346]. Chronic epileptiform discharges or epileptic foci in these areas may produce potentially life-threatening cardiac arrhythmias both ictally and interictally as cardiovascular regulation is, in fact, a function of neuronal activity in the cerebral cortex, the amygdale, and the medullary reticular formation [18, 29, 4346]. It has been suggested in the context of increased preictal HR that in patients with primarily more instability and activation in cortical networks surrounding the seizure onset zone will simultaneously increase sympathetic tone and risk for generalization of the seizure, since noradrenergic function may be needed for the anticonvulsive effect of the vagus nerve stimulation, at least in animals [47]. However, on the other hand, it has also been shown that secondarily generalized seizures lead to higher ictal HR and sustained postictal tachycardia with enhanced shortening of QT-interval possible showing that cardiac alterations are in fact a link between generalized seizures and SUDEP [48]. In this study, TLE patients showed altered sympathovagal balance in the interictal state. During the dynamic test situation, especially refractory TLE patients showed decreased reactivity of the cardiac autonomic functions with the breakdown of sympathovagal balance. In the future it would be interesting to study interictal and ictal cardiac measures to evaluate whether interictal changes in HR correlate with ictal HR changes in the same patient.

Chronic epilepsy with recurrent generalized seizures is known to be associated with a high risk of SUDEP [49, 50]. SUDEP is the utmost consequence of numerous different factors that precipitate fatal complications of an epileptic activity in a predisposed person [27, 28, 30, 31, 4951]. As the knowledge and understanding of the pathophysiological background of SUDEP increases, it is necessary to continue to develop methods to study ANS function in patients with epilepsy along with identifying the clinical risk markers. These methods may eventually provide tools to identify epilepsy patients with ANS dysfunction and risk of SUDEP and allow preventive actions.

The limitation of our study was the small number of patients that were evaluated. It is possible that a higher number of patients would have established more statistically significant differences between the study groups. Because of the unbalanced male-to-female ratio we cannot conclude that these results apply to both genders.

In conclusion, spectral HR variation during autonomic function tests is a useful tool to study autonomic cardiac regulation in patients with epilepsy. When the autonomic cardiac function tests are performed under standardized laboratory conditions according to a regular protocol, the method is reliable. The reactivity of the cardioregulatory functions can be assessed more carefully by including spectral analysis of HR variation into the study protocol. TLE patients showed a sympathovagal malfunction during the dynamic test situation. This was even more pronounced in patients with refractory TLE. Although reduced HR variation is not considered a direct indication of elevated risk of SUDEP, the inferior capacity of the ANS to react during dynamic situations may be a manifestation of autonomic imbalance during generalized epileptic seizures.

Conflict of Interests

The authors declared that there are no conflict of interests to disclose.

Acknowledgment

The authors confirm that they have read the journal’s position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.

References

  1. B. B. Wannamaker, “Autonomic nervous system and epilepsy,” Epilepsia, vol. 26, no. 1, pp. S31–S39, 1985. View at: Google Scholar
  2. O. Devinsky, Effects of Seizures on Autonomic and Cardiovascular Function, Blackwell, 2004.
  3. J. A. Messenheimer, S. R. Quint, M. B. Tennison, and P. Keaney, “Monitoring heart period variability changes during seizures. I. Methods,” Journal of Epilepsy, vol. 3, no. 1, pp. 47–54, 1990. View at: Publisher Site | Google Scholar
  4. O. Devinsky, K. Perrine, and W. H. Theodore, “Interictal autonomic nervous system function in patients with epilepsy,” Epilepsia, vol. 35, no. 1, pp. 199–204, 1994. View at: Google Scholar
  5. R. Massetani, G. Strata, R. Galli et al., “Alteration of cardiac function in patients with temporal lobe epilepsy: different roles of EEG-ECG monitoring and spectral analysis of RR variability,” Epilepsia, vol. 38, no. 3, pp. 363–369, 1997. View at: Publisher Site | Google Scholar
  6. J. I. T. Isojärvi, H. Ansakorpi, K. Suominen, U. Tolonen, M. Repo, and V. V. Myllylä, “Interictal cardiovascular autonomic responses in patients with epilepsy,” Epilepsia, vol. 39, no. 4, pp. 420–426, 1998. View at: Publisher Site | Google Scholar
  7. T. Tomson, M. Ericson, C. Ihrman, and L. E. Lindblad, “Heart rate variability in patients with epilepsy,” Epilepsy Research, vol. 30, no. 1, pp. 77–83, 1998. View at: Publisher Site | Google Scholar
  8. H. Ansakorpi, J. T. Korpelainen, K. Suominen, U. Tolonen, V. V. Myllylä, and J. I. T. Isojärvi, “Interictal cardiovascular autonomic responses in patients with temporal lobe epilepsy,” Epilepsia, vol. 41, no. 1, pp. 42–47, 2000. View at: Google Scholar
  9. C. Baumgartner, S. Lurger, and F. Leutmezer, “Autonomic symptoms during epileptic seizures,” Epileptic Disorders, vol. 3, no. 3, pp. 103–116, 2001. View at: Google Scholar
  10. H. Ansakorpi, J. T. Korpelainen, H. V. Huikuri, U. Tolonen, V. V. Myllylä, and J. I.T. Isojärvi, “Heart rate dynamics in refractory and well controlled temporal lobe epilepsy,” Journal of Neurology Neurosurgery and Psychiatry, vol. 72, no. 1, pp. 26–30, 2002. View at: Publisher Site | Google Scholar
  11. E. Ronkainen, H. Ansakorpi, H. V. Huikuri, V. V. Myllylä, J. I.T. Isojärvi, and J. T. Korpelainen, “Suppressed circadian heart rate dynamics in temporal lobe epilepsy,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 76, no. 10, pp. 1382–1386, 2005. View at: Publisher Site | Google Scholar
  12. R. Freeman, “Cardiovascular manifestations of autonomic epilepsy,” Clinical Autonomic Research, vol. 16, no. 1, pp. 12–17, 2006. View at: Publisher Site | Google Scholar
  13. H. Persson, E. Kumlien, M. Ericson, and T. Tomson, “Circadian variation in heart-rate variability in localization-related epilepsy,” Epilepsia, vol. 48, no. 5, pp. 917–922, 2007. View at: Publisher Site | Google Scholar
  14. J. Janszky, A. Fogarasi, V. Toth et al., “Peri-ictal vegetative symptoms in temporal lobe epilepsy,” Epilepsy & Behavior, vol. 11, no. 1, pp. 125–129, 2007. View at: Publisher Site | Google Scholar
  15. T. Harnod, C. C. H. Yang, Y. L. Hsin, P. J. Wang, K. R. Shieh, and T. B. J. Kuo, “Heart rate variability in patients with frontal lobe epilepsy,” Seizure, vol. 18, no. 1, pp. 21–25, 2009. View at: Publisher Site | Google Scholar
  16. S. Mukherjee, M. Tripathi, P. S. Chandra et al., “Cardiovascular autonomic functions in well-controlled and intractable partial epilepsies,” Epilepsy Research, vol. 85, no. 2-3, pp. 261–269, 2009. View at: Publisher Site | Google Scholar
  17. R. Surges, C. Henneberger, P. Adjei, C. A. Scott, J. W. Sander, and M. C. Walker, “Do alterations in inter-ictal heart rate variability predict sudden unexpected death in epilepsy?” Epilepsy Research, vol. 87, no. 2-3, pp. 277–280, 2009. View at: Publisher Site | Google Scholar
  18. R. Surges, C. A. Scott, and M. C. Walker, “Peri-ictal atrioventricular conduction block in a patient with a lesion in the left insula: case report and review of the literature,” Epilepsy & Behavior, vol. 16, no. 2, pp. 347–349, 2009. View at: Publisher Site | Google Scholar
  19. E. Suorsa, J. T. Korpelainen, H. Ansakorpi et al., “Heart rate dynamics in temporal lobe epilepsy—a long-term follow-up study,” Epilepsy Research, vol. 93, no. 1, pp. 80–83, 2011. View at: Publisher Site | Google Scholar
  20. H. V. Barron and S. Viskin, “Autonomic markers and prediction of cardiac death after myocardial infarction,” The Lancet, vol. 351, no. 9101, pp. 461–462, 1998. View at: Publisher Site | Google Scholar
  21. P. J. Schwartz and M. T. La Rovere, “ATRAMI: a mark in the quest for the prognostic value of autonomic markers,” European Heart Journal, vol. 19, no. 11, pp. 1593–1595, 1998. View at: Publisher Site | Google Scholar
  22. V. Pursiainen, T. H. Haapaniemi, J. T. Korpelainen, H. V. Huikuri, K. A. Sotaniemi, and V. V. Myllylä, “Circadian heart rate variability in Parkinson's disease,” Journal of Neurology, vol. 249, no. 11, pp. 1535–1540, 2002. View at: Publisher Site | Google Scholar
  23. P. H. Riihimaa, K. Suominen, M. Knip, P. Tapanainen, and U. Tolonen, “Cardiovascular autonomic reactivity is decreased in adolescents with type 1 diabetes,” Diabetic Medicine, vol. 19, no. 11, pp. 932–938, 2002. View at: Publisher Site | Google Scholar
  24. A. M. Mäkikallio, T. H. Mäkikallio, J. T. Korpelainen, K. A. Sotaniemi, H. V. Huikuri, and V. V. Myllylä, “Heart rate dynamics predict poststroke mortality,” Neurology, vol. 62, no. 10, pp. 1822–1826, 2004. View at: Google Scholar
  25. M. Malik, “Heart rate variability: standards of measurement, physiological interpretation, and clinical use,” Circulation, vol. 93, no. 5, pp. 1043–1065, 1996. View at: Google Scholar
  26. N. Eppinger, R. Schaumann, H. Jokeit, U. Buettner, and G. Kraemer, “Reduced heart rate variability (HRV) in victims of sudden death in epilepsy (SUDEP),” Epilepsia, vol. 45, p. 65, 2004. View at: Google Scholar
  27. M. Nei, R. T. Ho, B. W. Abou-Khalil et al., “EEG and ECG in sudden unexplained death in epilepsy,” Epilepsia, vol. 45, no. 4, pp. 338–345, 2004. View at: Publisher Site | Google Scholar
  28. S. M. Oppenheimer, D. F. Cechetto, and V. C. Hachinski, “Cerebrogenic cardiac arrhythmias. Cerebral electrocardiographic influences and their role in sudden death,” Archives of Neurology, vol. 47, no. 5, pp. 513–519, 1990. View at: Google Scholar
  29. S. M. Oppenheimer, A. Gelb, J. P. Girvin, and V. C. Hachinski, “Cardiovascular effects of human insular cortex stimulation,” Neurology, vol. 42, no. 9, pp. 1727–1732, 1992. View at: Google Scholar
  30. E. L. So, M. C. Sam, and T. L. Lagerlund, “Postictal central apnea as a cause of SUDEP: evidence from near-SUDEP incident,” Epilepsia, vol. 41, no. 11, pp. 1494–1497, 2000. View at: Google Scholar
  31. C. Stöllberger and J. Finsterer, “Cardiorespiratory findings in sudden unexplained/unexpected death in epilepsy (SUDEP),” Epilepsy Research, vol. 59, no. 1, pp. 51–60, 2004. View at: Publisher Site | Google Scholar
  32. F. J. Rugg-Gunn, R. J. Simister, M. Squirrell, D. R. Holdright, and P. J. S. Duncan, “Cardiac arrhythmias in focal epilepsy: a prospective long-term study,” The Lancet, vol. 364, no. 9452, pp. 2212–2219, 2004. View at: Publisher Site | Google Scholar
  33. V. Toth, L. Hejjel, A. Fogarasi et al., “Periictal heart rate variability analysis suggests long-term postictal autonomic disturbance in epilepsy,” European Journal of Neurology, vol. 17, no. 6, pp. 780–787, 2010. View at: Publisher Site | Google Scholar
  34. S. J. Piha, “Cardiovascular responses to various autonomic tests in males and females,” Clinical Autonomic Research, vol. 3, no. 1, pp. 15–20, 1993. View at: Google Scholar
  35. K. Suominen, “Design and implementation of a PC-based data acquisition system for measuring ECG and respiratory signals,” International Journal of Clinical Monitoring and Computing, vol. 14, no. 4, pp. 225–230, 1997. View at: Publisher Site | Google Scholar
  36. C. M. DeGiorgio, P. Miller, S. Meymandi et al., “RMSSD, a measure of vagus-mediated heart rate variability, is associated with risk factors for SUDEP: the SUDEP-7 inventory,” Epilepsy & Behavior, vol. 19, no. 1, pp. 78–81, 2010. View at: Publisher Site | Google Scholar
  37. J. Roger, F. E. Dreifuss, M. Martinez-Lage et al., “Proposal for revised classification of epilepsies and epileptic syndromes,” Epilepsia, vol. 30, no. 4, pp. 389–399, 1989. View at: Google Scholar
  38. A. Druschky, M. J. Hilz, P. Hopp et al., “Interictal cardiac autonomic dysfunction in temporal lobe epilepsy demonstrated by [123 I]metaiodobenzylguanidine-SPECT,” Brain, vol. 124, no. 12, pp. 2372–2382, 2001. View at: Google Scholar
  39. M. J. Hennessy, M. G. Tighe, C. D. Binnie, and L. Nashef, “Sudden withdrawal of carbamazepine increases cardiac sympathetic activity in sleep,” Neurology, vol. 57, no. 9, pp. 1650–1654, 2001. View at: Google Scholar
  40. H. Persson, M. Ericson, and T. Tomson, “Carbamazepine affects autonomic cardiac control in patients with newly diagnosed epilepsy,” Epilepsy Research, vol. 57, no. 1, pp. 69–75, 2003. View at: Publisher Site | Google Scholar
  41. M. I. Lossius, J. E. Erikssen, P. Mowinckel, P. Gulbrandsen, and L. Gjerstad, “Changes in autonomic cardiac control in patients with epilepsy after discontinuation of antiepileptic drugs: a randomized controlled withdrawal study,” European Journal of Neurology, vol. 14, no. 9, pp. 1022–1028, 2007. View at: Publisher Site | Google Scholar
  42. V. V. Myllylä, J. T. Korpelainen, T. H. Haapaniemi et al., “Cardiovascular autonomic dysregulation,” in Handbook of the Autonomic Nervous System in Health and Disease, L. C. Bolis, J. Licino, and S. Govoni, Eds., pp. 181–237, Marcel Dekker, New York, NY, USA, 2002. View at: Google Scholar
  43. P. L. Schraeder and C. M. Lathers, “Paroxysmal autonomic dysfunction, epileptogenic activity and sudden death,” Epilepsy Research, vol. 3, no. 1, pp. 55–62, 1989. View at: Google Scholar
  44. M. Lanz, B. Oehl, A. Brandt, and A. Schulze-Bonhage, “Seizure induced cardiac asystole in epilepsy patients undergoing long term video-EEG monitoring,” Seizure, vol. 20, no. 2, pp. 167–172, 2010. View at: Publisher Site | Google Scholar
  45. M. Nei, A. T. Zangaladze, A. Sharan, and R. T. Ho, “Interictal epileptiform discharges and asystole,” Epilepsy Research, vol. 93, no. 2-3, pp. 204–207, 2011. View at: Publisher Site | Google Scholar
  46. A. Serafini, P. Gelisse, V. Reana, and A. Crespel, “Cardiac asystole during a cluster of right temporo-parietal seizures,” Seizure, vol. 20, no. 2, pp. 181–183, 2010. View at: Publisher Site | Google Scholar
  47. K. B. Nilsen, M. Haram, S. Tangedal, T. Sand, and E. Brodtkorb, “Is elevated pre-ictal heart rate associated with secondary generalization in partial epilepsy?” Seizure, vol. 19, no. 5, pp. 291–295, 2010. View at: Publisher Site | Google Scholar
  48. R. Surges, C. A. Scott, and M. C. Walker, “Enhanced QT shortening and persistent tachycardia after generalized seizures,” Neurology, vol. 74, no. 5, pp. 421–426, 2010. View at: Publisher Site | Google Scholar
  49. R. Surges, R. D. Thijs, H. L. Tan, and J. W. Sander, “Sudden unexpected death in epilepsy: risk factors and potential pathomechanisms,” Nature Reviews Neurology, vol. 5, no. 9, pp. 492–504, 2009. View at: Publisher Site | Google Scholar
  50. L. Nobili, P. Proserpio, G. Rubboli, N. Montano, G. Didato, and C. A. Tassinari, “Sudden unexpected death in epilepsy (SUDEP) and sleep,” Sleep Medicine Reviews, vol. 15, no. 4, pp. 237–246, 2010. View at: Publisher Site | Google Scholar
  51. G. B. Richerson and G. F. Buchanan, “The serotonin axis: shared mechanisms in seizures, depression, and SUDEP,” Epilepsia, vol. 52, supplement 1, pp. 28–38, 2011. View at: Publisher Site | Google Scholar

Copyright © 2011 Hanna Ansakorpi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

1298 Views | 600 Downloads | 3 Citations
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.